Attorney Scott Barshay
Client Mylan Pharmaceuticals Inc.
Notes Represented Mylan Pharmaceuticals in its successful takeover defense against Teva’s $40 billion hostile bid and in Mylan’s offer to acquire Perrigo for $35 billion
Updated over 7 years ago

Source Links